Strawberry Moon 2026: Skywatchers worldwide are in for a treat as the Strawberry Moon graces the night sky on June 29 and 30. While Norther...

Indian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving average...

The President of Seychelles, Patrick Herminie, on Sunday conferred the honorary title of "Guardian of the Blue Horizon" on Prime Minister N...

The interesting point about the large-cap space today is not that prices have collapsed. In most cases, they have not. The more important c...

David Swensen emphasised the importance of maintaining an equity bias for long-term investors, noting that stocks tend to deliver stronger ...

Alembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for influenza. Th...

Strawberry Moon 2026: Skywatchers are in for a treat as the Strawberry Moon graces the night sky on June 29, 2026. While not red, this full...

India is set to implement a mandatory registration for printed pharmaceutical packaging manufacturers to combat counterfeit drugs. This mov...

A historic black hole discovery is changing how scientists explore the universe. Researchers have detected possible fingerprints of a black...

A powerful black hole collision has opened a new chapter in space science. Scientists used the loudest gravitational wave signal ever detec...

Indian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...

Foreign institutional investors (FIIs) reversed their selling trend in six select Indian stocks, turning them into multibaggers. Bajaj Cons...

India's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...

Smallcap funds have emerged as the best-performing equity mutual fund category over the last three months, delivering an average return of ...

Fixed dose combination banned full list: India has banned 16 fixed-dose combination drugs, including certain antibiotics and antispasmodics...

In a significant public health initiative, the ban on 16 fixed-dose drug combinations, including various antibiotics and topical formulatio...

Horizon Reclaim (India) debuted on the BSE SME platform with a 46.6% premium, listing at Rs 151 against its IPO price of Rs 103. The Rs 54....